Can somebody please answer a few of my questions
1) Are paracrine, autocrine, juxtacrine signalling molecules considered hormones, or are hormones only endocrine (some old vcaa exams say that endocrine isnt only type of hormone)
2) In terms of defining autoimmune disorder, should we say self antigens are recognised as non self or self cells are recognised as non self?
3) What do they mean by "types of treatments" in the study design dotpoint, asides from vaccinations, antivirals/antibiotics, what else could this encompass?
4) In the 2015 VCAA exam, q7c asks "how the same genetic sequence could lead to distinct proteins in different cell types" and the answer suggests that it is due to factors expressed by regulatory genes causing this. However, on the previous page, it discusses how the hormone causing this binds upstream to one specific gene (growth hormone gene), so if one gene causes different proteins to be produced, would discussing alternative splicing and exon juggling causing different proteins in each cell suffice as an answer?
5) If we had to discuss the autoimmune response for multiple sclerosis, do we discuss the myelin sheath being destroyed or the oligodendrocytes?
Extremely sorry for the long questions but I would appreciate it if someone could answer. Thank you!
1. As far as I am aware, the ONLY* type of hormones are endocrine... *EXCEPT, in terms of plant HORMONES (/ plant growth regulators) that do not use endocrine signalling (due to lack of bloodstream). The autocrine, paracrine and juxtacrine/cell-to-cell/contact-dependent signalling all merely involve 'signalling molecules'. Now, a piece of evidence that strengthens what I have just stated is that neurotransmitters are classified under paracrine signalling... which most definitely is NOT a group of hormones....
2. Definitely say ANTIGENS. Immune cells do not recognise other CELLS per se, but rather recognise other cell's antigens. In autoimmunity, these antigens are identified as NON SELF and an immune response is mounted against cells containing these ANTIGENS.
3. This would encompass the types of treatments against pathogens, which I would suspect would involve vaccinations and antibiotics/antivirals as you mentioned.... however, this is one of those vague dot points where I could only guess... maybe: antimycotics, antihelminths... not sure to be honest... maybe even monoclonal antibodies.. I really wouldn't sweat it..
4. Yeah.. I have encountered this question multiple times with different people. I also agree with your answer (an answer that many other people also believe is correct). Their answer is far too vague - I have actually answered this question a few pages back - however, I made the assumption that there was more than one GRE binding site (in an attempt to make logic of the VCAA answer). But I most definitely believe that the BEST answer involves mention of alternative splicing or exon juggling. (By the way - be careful, the question only made mention of the GRE being upstream of the GH gene, not the 'specific' GH gene - a subtle difference).
5. Both would technically be correct answers., however, within the scope of the study design just mention the myelin sheath.
Good luck!